Search Results

You are looking at 61 - 70 of 255 items for :

  • papillary thyroid carcinoma x
Clear All
Darshan Patil Department of Surgical Oncology, HCG-Bangalore Institute of Oncology, Bangalore, India

Search for other papers by Darshan Patil in
Google Scholar
PubMed
Close
,
Abhay Kumaraswamy Kattepur Department of Surgical Oncology, HCG-Bangalore Institute of Oncology, Bangalore, India

Search for other papers by Abhay Kumaraswamy Kattepur in
Google Scholar
PubMed
Close
,
Srinivas Kodaganur Gopinath Department of Surgical Oncology, HCG-Bangalore Institute of Oncology, Bangalore, India

Search for other papers by Srinivas Kodaganur Gopinath in
Google Scholar
PubMed
Close
,
Shivanand Swamy Department of Surgical Oncology, HCG-Bangalore Institute of Oncology, Bangalore, India

Search for other papers by Shivanand Swamy in
Google Scholar
PubMed
Close
,
Amarendra Shankarappa Department of Surgical Oncology, HCG-Bangalore Institute of Oncology, Bangalore, India

Search for other papers by Amarendra Shankarappa in
Google Scholar
PubMed
Close
, and
Gopinath Kodaganur Srinivasachar Department of Surgical Oncology, HCG-Bangalore Institute of Oncology, Bangalore, India

Search for other papers by Gopinath Kodaganur Srinivasachar in
Google Scholar
PubMed
Close

from the follicular carcinoma of the thyroid. Introduction Well-differentiated thyroid cancers include both the papillary and follicular varieties. Follicular thyroid cancers are more aggressive than their papillary counterparts with

Free access
José I. López Department of Pathology, Cruces University Hospital, BioCruces Research Institute, University of the Basque Country, Barakaldo

Search for other papers by José I. López in
Google Scholar
PubMed
Close
,
Rosa Zabala Department of Radiology, Basurto University Hospital, University of the Basque Country, Bilbao, Spain

Search for other papers by Rosa Zabala in
Google Scholar
PubMed
Close
, and
José Luís del Cura Department of Radiology, Basurto University Hospital, University of the Basque Country, Bilbao, Spain

Search for other papers by José Luís del Cura in
Google Scholar
PubMed
Close

How It is useful for the pathologist to first analyse surgical specimens of thyroid tissue with common diseases such as goitre, thyroiditis, and papillary thyroid carcinoma, as well as ‘histologically normal' tissue, analysing them under high

Free access
Neslihan Kurtulmus Endocrinology and Thyroid Clinic, Acibadem Maslak Hospital, Istanbul, Turkey

Search for other papers by Neslihan Kurtulmus in
Google Scholar
PubMed
Close
,
Burak Ertas Departments of Otorhinolaryngology, Istanbul, Turkey

Search for other papers by Burak Ertas in
Google Scholar
PubMed
Close
,
Yesim Saglican Pathology, Medical Faculty, Acibadem University, Istanbul, Turkey

Search for other papers by Yesim Saglican in
Google Scholar
PubMed
Close
,
Hakan Kaya Endocrinology and Thyroid Clinic, Acibadem Maslak Hospital, Istanbul, Turkey

Search for other papers by Hakan Kaya in
Google Scholar
PubMed
Close
,
Umit Ince Pathology, Medical Faculty, Acibadem University, Istanbul, Turkey

Search for other papers by Umit Ince in
Google Scholar
PubMed
Close
, and
Mete Duren Endocrinology and Thyroid Clinic, Acibadem Maslak Hospital, Istanbul, Turkey

Search for other papers by Mete Duren in
Google Scholar
PubMed
Close

. Lymphocytic infiltration in nontumoral tissue was detected in 32 patients (62.7%). Despite not being statistically significant, this rate was considered to be high. The majority of the patients (n = 45, 88.2%) had conventional papillary thyroid carcinoma, but

Free access
Marta Nascimento Soares Faculty of Medicine of the University of Porto, Porto, Portugal

Search for other papers by Marta Nascimento Soares in
Google Scholar
PubMed
Close
,
Marta Borges-Canha Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal

Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed
Close
,
Celestino Neves Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal

Search for other papers by Celestino Neves in
Google Scholar
PubMed
Close
,
João Sérgio Neves Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal

Search for other papers by João Sérgio Neves in
Google Scholar
PubMed
Close
, and
Davide Carvalho Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal

Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Close

papillary thyroid carcinoma (PTC), follicular thyroid carcinoma, and oncocitic cell carcinoma of the thyroid ( 5 ). PTC is the most common histological subtype of differentiated thyroid malignancy, constituting about 80% of cases ( 6 ). The age of

Open access
Pedro Weslley Souza Rosario Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed
Close

. Although rare, FNA may detect uncommon tumors (such as medullary carcinoma or aggressive variants of papillary thyroid cancer) that are not candidates for active surveillance [ 2 ]. Disclosure Statement No competing financial interests exist

Free access
Mafalda Marcelino Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal
Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Close
,
Pedro Marques Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Pedro Marques in
Google Scholar
PubMed
Close
,
Luis Lopes Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal

Search for other papers by Luis Lopes in
Google Scholar
PubMed
Close
,
Valeriano Leite Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close
, and
João Jácome de Castro Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal

Search for other papers by João Jácome de Castro in
Google Scholar
PubMed
Close

seen as a protective condition for thyroid cancer, and a relationship between low serum TSH levels and a lower incidence of papillary carcinoma has been suggested [ 6 , 7 ]. However, a recent meta-analysis could not confirm this association [ 8

Free access
Furio Pacini Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy

Search for other papers by Furio Pacini in
Google Scholar
PubMed
Close

Differentiated thyroid carcinoma (DTC) accounts for more than 80% of all thyroid cancers. An increasing incidence of DTC over the last decades has been reported worldwide, and is mainly due to the discovery of small papillary carcinomas [ 1

Free access
Yalin Iscan Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Yalin Iscan in
Google Scholar
PubMed
Close
,
Ismail Cem Sormaz Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Ismail Cem Sormaz in
Google Scholar
PubMed
Close
,
Fatih Tunca Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Fatih Tunca in
Google Scholar
PubMed
Close
, and
Yasemin Giles Senyurek Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Yasemin Giles Senyurek in
Google Scholar
PubMed
Close

Introduction Papillary carcinoma is the most common histopathologic type of malignancy of the thyroid [ 1 ]. Papillary microcarcinoma (PMC) is defined as a thyroid cancer measuring ≤1 cm in greatest diameter by the World Health Organization

Free access
Carles Zafon Department of Endocrinology, Hospital Vall d'Hebron, and Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona and CIBERDEM (ISCIII), Barcelona

Search for other papers by Carles Zafon in
Google Scholar
PubMed
Close
,
Juan J. Díez Department of Endocrinology and Nutrition, Hospital Ramón y Cajal
Department of Medicine, University of Alcalá de Henares, Madrid

Search for other papers by Juan J. Díez in
Google Scholar
PubMed
Close
,
Juan C. Galofré Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain
IdiSNA (Instituto de investigación en la salud de Navarra), Pamplona, Spain

Search for other papers by Juan C. Galofré in
Google Scholar
PubMed
Close
, and
David S. Cooper Division of Endocrinology, Diabetes and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Search for other papers by David S. Cooper in
Google Scholar
PubMed
Close

in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity? J Int Med Res 2013;41:975-983. 8 Das DK, Al-Waheeb SKM, George SS, Haji BI, Mallik MK: Contribution of immunocytochemical stainings for galectin-3

Free access
Tim Brandenburg Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Search for other papers by Tim Brandenburg in
Google Scholar
PubMed
Close
,
Philipp Muchalla Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Search for other papers by Philipp Muchalla in
Google Scholar
PubMed
Close
,
Sarah Theurer Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
University Duisburg-Essen, Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Search for other papers by Sarah Theurer in
Google Scholar
PubMed
Close
,
Kurt Werner Schmid Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
University Duisburg-Essen, Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Search for other papers by Kurt Werner Schmid in
Google Scholar
PubMed
Close
, and
Dagmar Führer Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Close

Nikiforova MN , Kimura ET , Gandhi M , Biddinger PW , Knauf JA , Basolo F , . BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas . J Clin

Free access